North America Western Blotting Market Report

North America Western Blotting Market Size

The size of the North America western blotting market was worth USD 246 million in 2024. The North America market is anticipated to grow at a CAGR of 5.2% from 2025 to 2033 and be worth USD 388 million by 2033 from USD 259 million in 2025.

MARKET SCENARIO

North-America accounts for the largest share of the market. It can be attributed to the rise in the prevalence of HIV and Lyme disease, U.S. & China combined program for biomedical research, upsurge in research funding and rise in the production of genetically modified crops in the U.S., HIV vaccine initiative, and growth in the intensity of pharmaceutical and biopharmaceutical clinical research in Canada.

Western blotting is a technique widely used in the study of proteomics. Proteomics is used to study how proteins are expressed in biological systems.

The growth of the Western blotting market in North America is mainly attributed to investments in proteomics research and the increasing prevalence of Lyme and HIV. On the other hand, the automation of the Western transfer technique is likely to positively impact the growth of the North American Western blotting market in the years to come. The increasing number of research and development and clinical activities is likely to increase the market.

Alternative technologies for protein detection are likely to impact the growth of the market negatively. On the other hand, the automation of the Western transfer technique is expected to positively impact the development of the North American Western transfer market in the coming years.

COUNTRY LEVEL ANALYSIS

Regionally, the North American western blotting market is estimated to rule the global western blotting market during the forecast period. The growth in the market can be attributed to the increasing ubiquity of Lyme, and HIV contributes to the development of the market. The increase in research and business spending is expanding the market. Western Blot is a method used to detect and analyze protein molecules in a specific complex sample by volume, weight, and electrophoresis. The other method is carried out on another Western blot membrane, typically comprising nitrocellulose or polyvinylidene difluoride (PVDF). A particular system prevents the non-specific binding of antibodies from controlling it. The western blotting industry holds the majority of the molecular diagnostics market share in terms of revenue. It is widely applicable in agriculture and disease diagnosis.

In Canada, Genome Canada, funded by the Government of Canada, is developing genomics + and genomics-based technologies to create social and economic benefits for Canadians. In June 2020, the organization invested USD 43.4 million in federal funds to support 20 research projects. This investment will support essential research collaborations in genomics research. Besides, the UVic-Genome BC Proteomics Center is Canada's most advanced proteomics research facility, used by government, academic, and industry researchers worldwide.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Western blotting market profiled in this report are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.

MARKET SEGMENTATION

This research report on the North America western blotting market is segmented and sub-segmented into the following categories.

By Product

• Instruments

• Consumables

By Application

• Biomedical & Biochemical Research

• Disease Diagnostics

By End User

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

By Country

• United States
• Canada
• Mexico
• Rest of North America